If you ask the various stakeholders in the patient recruitment process who is most at fault when it comes to the ineffectiveness of how things usually operate, you’ll probably get responses such as sponsors pointing to research sites for not following up the referrals in a timely fashion, sites pointing to CROs for not providing adequate support, patients pointing to sponsors regarding the burden of trial protocols, etc.

In my experience with trials, it’s rarely one major issue that causes the problems. More likely a combination of these and other factors that contribute to bottlenecks and delays at each point.

And, while taking on board what the other stakeholders are saying is obviously worthwhile, I would suggest that maybe looking inwards can also help with developing solutions.

Each stakeholder asking themself what they could do better should result in more effective practices being adopted, and better outcomes for all.

You may also like

Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...
Key C-suite Roles for Biotech Success - The Chief Operating Officer (COO)
The biotech Chief Operating Officer (COO) ensures that strategy is executed effectively - on time, on budget, and without surprises.  COOs can often oversee clinical operations, vendor ...